Cancer Care

Biotechnology

Syndax Pharmaceuticals Secures $350 Million in Funding to Revolutioniz...

Syndax Pharmaceuticals has secured $350 million to accelerate the development of innovative cancer t...

Biotechnology

Syndax Pharmaceuticals Secures $350 Million in Funding to Revolutioniz...

Syndax Pharmaceuticals has secured $350 million to enhance its cancer treatment pipeline, focusing o...

Healthcare

Breaking Barriers: Oncovana Secures Funding to Expand Access to Cancer...

Oncovana has secured $5 million in funding to enhance access to cancer-related fertility services an...